Поиск | Myliveroom — Live Events & Online Communities

Sameer Shewale добавлена новая статья Активировано
2026-05-04 07:47:54 - Перевод -

Anti-Rheumatics Market Size to Reach USD 84.18 Billion by 2033, Driven by Rising Prevalence of Autoimmune Disorders
Market Overview The global Anti-Rheumatics Market is witnessing steady growth, driven by the increasing prevalence of autoimmune diseases such as rheumatoid arthritis and other inflammatory conditions. According to the latest report by Straits Research, the market was valued at USD 66.24 billion in 2024 and is projected to reach USD 84.18 billion by 2033, growing at a CAGR of 2.7% during...

0 Комментарии 0 Поделились 676 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
Rohit More добавлена новая статья Networking
2026-06-17 05:31:13 - Перевод -

Janus Kinase (JAK) Inhibitor Drugs Market Advances with Expanding Use of Targeted Therapies for Autoimmune and Inflammatory Disorders
According to the latest report published by Data Bridge Market Research, the Janus Kinases (JAKs) Inhibitor Drugs Market Data Bridge Market Research analyses that the Janus kinases (JAKs) inhibitor drugs market, which is USD 2.45 billion in 2022, is expected to reach USD 5.11 billion by 2030, at a CAGR of 9.6% during the forecast period 2023 to 2030 Global Janus Kinases (JAKs)...

0 Комментарии 0 Поделились 192 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
Ksh Dbmr добавлена новая статья Networking
2025-11-03 07:03:20 - Перевод -

How the Ustekinumab Market Is Redefining Biologic Therapies for Autoimmune Diseases?
Executive Summary Ustekinumab Market Opportunities by Size and Share CAGR Value The global ustekinumab market size was valued at USD 12.07 billion in 2024 and is expected to reach USD 19.09 billion by 2032, at a CAGR of 5.90% during the forecast period Ustekinumab Market research report is a verified and consistent source of information that puts forth a telescopic view of the...

0 Комментарии 0 Поделились 4Кб Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!